Our Clinical and Research Council

Our Clinical and Research Council is the Board's strategic advisory group on lung health, lung disease and lung cancer health policy. The multidisciplinary Council is made up of internationally and nationally recognised leaders in their relevant discipline or sector. Each Expert Committee Chair is represented ensuring the broadest cross section of views. The Council supports the Board by also providing strategic advice on our research priorities and emerging areas of interest.

Professor Christine McDonald 

Professor Christine McDonald AM is the Director of the Department of Respiratory and Sleep Medicine at Austin Health, Professorial Fellow, University of Melbourne and Medical Director of the Institute for Breathing and Sleep, Vic. She is a practising respiratory physician with longstanding clinical and research interests in non-pharmacological management of chronic lung disease, particularly COPD, oxygen therapy and pulmonary rehabilitation, and has over 200 publications.  She is lead author of the current Thoracic Society Guidelines on Domiciliary Oxygen and has published widely in this field, including seminal articles on ambulatory and palliative oxygen, current recipient of NHMRC funding to assess the use of ambulatory oxygen in interstitial lung disease (a multicentre international randomised controlled trial).  

Professor McDonald is a key contributor to Lung Foundation Australia’s clinical COPD program, having served on many committees, including:    

  • Chair of the COPD Clinical Advisory Committee   
  • Member of the Clinical and Research Council 
  • Member of the National Council 
  • Member of the Pulmonary Rehabilitation Network   
  • Member of the COPD-X Guidelines Clinical Committee  
  • Member of the COPD-X Concise Guide for Primary Care Writing Committee 
  • Member of the COVID-19 Expert Working Group 
  • Professor McDonald also supports Lung Foundation Australia educational events both for patients and health professionals.     

Professor McDonald was honoured in the Queen’s Birthday Honours list 2018 for significant service to respiratory and sleep medicine as a clinician-researcher, administrator and mentor, and to professional medical organisations.   

Professor Ian Yang

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, Metro North Hospital and Health Service; Head of the UQ Northside Clinical Unit and Professor, Faculty of Medicine, The University of Queensland, Brisbane. His clinical work is in the field of thoracic medicine, and his research team is studying gene-environmental interaction in COPD, asthma, lung cancer, smoking cessation and air pollution, and approaches to improving prevention, diagnosis and treatment of respiratory diseases. He is one of two Co-Chairs of the national COPD-X Guidelines Committee of Lung Foundation Australia. He is a member of editorial boards of respiratory journals, and serves as a Co-Chair of the Brisbane Diamantina Health Partners Chronic Disease Theme.

Professor Yang is a longstanding contributor to Lung Foundation Australia, having served on many committees, including:

  • Chair of the COPD-X Guidelines Clinical Advisory Committee
  • Member of the Clinical and Research Council
  • Member of the COPD Clinical Advisory Committee
  • Member of the COPD-X Concise Guide for Primary Care Writing Committee
  • Member of the Lungs in Action Expert Advisory Panel

Associate Professor Ian Glaspole

Associate Professor Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine Central Clinical School. He is the co-Chair of the Australian Idiopathic Pulmonary Fibrosis Registry, and a principal investigator in the Centre for Research Excellence in Pulmonary Fibrosis. He performs clinical and translational research of interstitial lung disease.

Associate Professor Glaspole is a longstanding contributor to Lung Foundation Australia, having served on many committees, including:

  • Chair of the Australian Idiopathic Pulmonary Fibrosis Registry Steering Committee
  • Member of the Clinical and Research Council
  • Member of Interstitial Lung Disease Registry Steering Committee
  • Member of the Rare Lung Disease Clinical Advisory Committee
  • Member of the Pulmonary Intestinal Vascular Organisation Taskforce
  • Member of the Pulmonary Fibrosis Australasian Clinical Trials Network (PACT)
  • Member of the Centre of Research Excellence in Pulmonary Fibrosis Translation and Education Subcommittee

Dr Kerry Hancock

Dr Kerry Hancock is a General Practitioner and has over 35 years’ experience in clinical practice. She graduated from Flinders University of South Australia Medical School in 1980 and established her own general practice, Chandlers Hill Surgery in 1985 in the outer southern suburbs of Adelaide. She remains one of the six  Principals in the practice, with  eleven  other GPs, nurses and  a clinical pharmacist, which  in three and a half decades has grown into a moderate to large sized group practice renowned for its training of general practitioners and  medical students and innovative practices to meet the needs of its community. Chandlers Hill Surgery was awarded Australian General Practice of the Year in 1999 and was also SA Practice of the Year in 2010.

For the last 25 years Dr Kerry Hancock has had a special interest in general practice based respiratory medicine and maintains strong affiliations with professional and consumer organisations such as RACGP, the International Primary Care Respiratory Group, Lung Foundation Australia,  Asthma Australia,  National Asthma Council of Australia,  and Cancer Australia.

Dr Hancock remains passionate for patients with respiratory conditions to access excellent clinical care by all primary care practitioners and to ensure that patients are diagnosed in a timely manner and provided with excellent care to achieve best outcomes for health and wellbeing. Dr Hancock’s active participation with respiratory organisations, government health services and research activities has enabled her to be involved in the development of national primary care focused respiratory management guidelines, educational activities and the development and promulgation of tools to assist GPs, Practice Nurses and Pharmacists in the management of their patients with respiratory disorders.

In 2018 Dr Hancock was awarded Honorary Fellowship Royal Australian College of General Practitioners (RACGP) for her services to general practice, respiratory medicine and teaching.

Dr Hancock is a longstanding contributor to Lung Foundation Australia, having served on many committees, including:

  • Inaugural Chair of the GP Advisory Group
  • Co-Chair of the Primary Care Clinical Advisory Committee
  • Member of the Clinical and Research Council
  • Member of the COPD Clinical Advisory Committee
  • Member of the COPD Nurses and Pharmacy Committees
  • Member of the COPD-X Concise Guide for Primary Care Writing Committee
  • Member of the Your Voice Lung Cancer Clinician Advocates Group

Professor Kwun Fong

Professor Kwun Fong is a Thoracic and Sleep Physician at The Prince Charles Hospital and Professor with the University of Queensland School of Medicine. He is Clinical Manager of the Pulmonary Malignancy Unit at The Prince Charles Hospital and Director of the University of Queensland Thoracic Research Centre which undertakes molecular, genomic and translational research in lung diseases.

Professor Fong has had the pleasure of working with the Lung Foundation Australia’s Lung Cancer program team for many years and is a proud volunteer for various committees, including:

  • Chair of the Australian Lung Cancer Conference
  • Chair of the Lung Cancer Clinical Advisory Group
  • Inaugural Chair of Australasian Lung Cancer Trials Group
  • Member of the National Council
  • Member of the Clinical and Research Council
  • Member of the Your Voice Lung Cancer Clinician Advocates Group

Associate Professor Lucy Morgan

Associate Professor Lucy Morgan is a Respiratory Physician in Sydney with clinical roles at Concord Hospital, Nepean Hospital and Macquarie University Private Hospital. She has had a long history with Lung Foundation Australia having been awarded the Lung Foundation Australia Boehringer Ingelheim COPD Fellowship in 1998, chaired the Lung Foundation Australia Palliative and Supportive Care Committee and the Respiratory Infectious Diseases Committee, been a member of the Australasian Lung Cancer Trials Group and COPD-X Committee, Lung Foundation Australia Clinical Council and more recently, Lead Clinician of Lung Foundation Australia’s Australian Bronchiectasis Registry. She is a passionate advocate for equity of access to benchmark clinical care for all Australians with lung disease and for gender equity in research and clinical leadership.

Associate Professor Morgan is a longstanding contributor to Lung Foundation Australia, having served on many committees, including:

  • Member of the Lung Foundation Australia Board of Directors
  • Chair of the Australian Bronchiectasis Registry Principal Investigators
  • Chair of the Australian Bronchiectasis Consortium
  • Deputy Chair of the Supportive and Palliative Care Advisory Committee
  • Member of the Clinical and Research Council
  • Member of the Australian Bronchiectasis Registry Scientific Committee
  • Member of the National Council
  • Member of the Respiratory Infectious Diseases Group

Associate Professor Nicole Goh

Associate Professor Nicole Goh is a Respiratory Physician and the Director of the Austin Hospital interstitial lung disease unit. She is a clinical associate professor within the faculty of Medicine at the University of Melbourne, Chair of the Medical and Scientific Research Committee at the Institute for breathing and sleep, Chair of the Lung foundation Australia rare lung disease group, and is on the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry and the Australian Interstitial lung disease Registry. She is involved in the Centre for Research Excellence in Pulmonary Fibrosis, working within the translational, educational and clinical trials arms. She is involved in clinical and translational research of interstitial lung diseases, with a particular focus on measures to improve the quality of lives of patients with interstitial lung disease.

Associate Professor Goh  is a longstanding contributor to Lung Foundation Australia, having served on many committees, including:

  • Chair of the Australian Rare Lung Disease Conference Organising Committee
  • Deputy Chair of the Australian Idiopathic Pulmonary Fibrosis Registry Steering Committee
  • Member of the Clinical and Research Council
  • Member of the Rare Lung Disease Clinical Advisory Committee
  • Member of the Interstitial Lung Disease Registry Steering Committee
  • Member of the National Council
  • Member of the Pulmonary Fibrosis Australasian Clinical Trials Network (PACT)
  • Member of the Pulmonary Interstitial Vascular Organisation Taskforce
  • Member of the Centre of Research Excellence in Pulmonary Fibrosis Translation and Education Subcommittee

Associate Professor Tamera Corte

Associate Professor Tamera Corte, BSc(Med), MBBS, FRACP, PhD, is a Consultant Respiratory Physician and Director of Interstitial Lung Disease in the Department of Respiratory Medicine at Royal Prince Alfred Hospital, and an Associate Professor at the University of Sydney.

She is Chief Investigator on a recently awarded Centre of Excellence NHMRC grant for Pulmonary Fibrosis, which strives to improve and extend the lives of patients living with pulmonary fibrosis through the development of a comprehensive and integrated program of basic and clinical research and education across Australia.  She is the founding Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry, the Australasian Interstitial Lung Disease Registry and a member of multiple international task forces for interstitial lung disease guidelines.

A/Prof Corte trained in respiratory medicine at the University of New South Wales in Sydney, Australia. She served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London with Professor Athol Wells. Dr Corte earned a doctor of philosophy degree in the identification of pulmonary vascular dysfunction in interstitial lung disease.  She continues her research at Sydney University, where her interests include the interstitial lung diseases as well as pulmonary vascular disease.

Associate Professor Corte volunteers on many Lung Foundation Australia committees focused on rare lung disease, including:

  • Chair of the Australasian Interstitial Lung Disease Registry Steering Committee
  • Chair of the Australian Idiopathic Pulmonary Fibrosis Registry Steering Committee
  • Member of the Clinical and Research Council
  • Member of the Rare Lung Disease Clinical Advisory Committee
  • Member of the Pulmonary Interstitial Vascular Organisation Taskforce
  • Treasurer and Member of the Pulmonary Fibrosis Australasian Clinical Trials Network (PACT)
  • Member of the Australasian Rare Lung Disease Conference Organising Committee
  • Member of the Centre of Research Excellence in Pulmonary Fibrosis Translation and Education Subcommittee
Tax 2022 Website pop up